SCHEMBL32690789

SCHEMBL32690789

Nc1cccc2c(=O)c(O)c(-c3ccccc3C(F)(F)F)[nH]c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ PARP1 P09874 3/20 0.41
▸ KDM4E B2RXH2 4/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ BLM P54132 1/20 0.39
▸ MCL1 Q07820 1/20 0.39
▸ KIF11 P52732 1/20 0.38
▸ STK10 O94804 4/20 0.37
▸ SLK Q9H2G2 4/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ CHEK1 O14757 1/20 0.37
▸ WEE1 P30291 1/20 0.37
▸ C1R P00736 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32690700 0.82 PARP1 (0.40) POLBTDP1PARP1KIF11STK10
SCHEMBL32690669 0.81 PARP1 (0.46) PARP1KMT2AMAPTALDH1A1
SCHEMBL32690706 0.79 AR (0.51) POLBTDP1PARP1KDM4EMEN1
SCHEMBL32690833 0.79 AR (0.51) PARP1KDM4EMEN1KMT2AKIF11
SCHEMBL32690747 0.75 PARP1 (0.34) PARP1KDM4ESTK10SLKMPL
SCHEMBL32690692 0.74 CHEK1 (0.43) POLBTDP1KDM4EMEN1LMNA
SCHEMBL32690672 0.74 PTGES (0.44) TDP1KDM4EMEN1LMNAKMT2A
SCHEMBL32690729 0.74 PARP14 (0.42) POLBMEN1KMT2A
SCHEMBL23270975 0.72 TRPA1 (0.44) POLBTDP1KDM4EMEN1KMT2A
Hydrochloric Acid SCHEMBL23271094 0.71 TRPA1 (0.43) POLBTDP1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition TAIWANJ PHARMACEUTICALS CO LTD (TW) 2026-03-26 — — US claimed
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition TAIWANJ PHARMACEUTICALS CO LTD (TW) 2026-03-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition NOX1, NOX4, CYBB POLB 266/4885TDP1 2552/4885PARP1 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback